Baochao Ji1, Boyong Xu1, Wentao Guo1, Aili Rehei1, Wenbo Mu1, Desheng Yang1, Li Cao2. 1. Department of Orthopaedics, First Affiliated Hospital of Xinjiang Medical University, 137 South LiYuShan Road, Urumqi, Xinjiang, 830054, China. 2. Department of Orthopaedics, First Affiliated Hospital of Xinjiang Medical University, 137 South LiYuShan Road, Urumqi, Xinjiang, 830054, China. xjbone@21cn.com.
Abstract
PURPOSE: Removal of an infected prosthesis was considered the gold standard for eradication of infection. However, removal of well-fixed components can result in structural bone damage and compromised reconstruction. In these situations we questioned whether the infection after the total hip arthroplasty could be treated effectively and retain the well-fixed implant in a single-stage exchange. METHODS: A retrospective analysis which included 31 patients with chronic infected THA who underwent major partial single-stage revision, including routinely exchanged femoral head and liner components, aggressive soft tissue debridement, removal of the femoral stem or acetabular cup and retention of the well-fixed component, thorough exposed component brushing, and adequate surgical soaking. Powdered Vancomycin was poured into the surgical area and the infection control rate and clinical outcomes were evaluated. The failure to treat the infection was defined as a recurrence of infection in the same hip. The average follow-up was five years (2-15 years). RESULT: There were four (12.9 %) failures during the study period at an average of 15 months (9-21 months) after partial single-stage revision. Of the 31 patients, 27 (87.1 %) patients had a satisfactory outcome and required no additional surgical or medical treatment for recurrence of infection. Acetabular cups were revised in 22 patients and femoral stems in nine patients. The mean post-operative Harris hip score at the most recent assessment was 74.6 (68-82). CONCLUSIONS: Treatment of chronic infected THA with retention of the well-fixed implant in a single-stage exchange can be fairly effective in the treatment of infection and achieving acceptable functional outcomes, which indicated that this may be an attractive alternative in highly selected patients. LEVEL OF EVIDENCE: Level IV, therapeutic study.
PURPOSE: Removal of an infected prosthesis was considered the gold standard for eradication of infection. However, removal of well-fixed components can result in structural bone damage and compromised reconstruction. In these situations we questioned whether the infection after the total hip arthroplasty could be treated effectively and retain the well-fixed implant in a single-stage exchange. METHODS: A retrospective analysis which included 31 patients with chronic infectedTHA who underwent major partial single-stage revision, including routinely exchanged femoral head and liner components, aggressive soft tissue debridement, removal of the femoral stem or acetabular cup and retention of the well-fixed component, thorough exposed component brushing, and adequate surgical soaking. Powdered Vancomycin was poured into the surgical area and the infection control rate and clinical outcomes were evaluated. The failure to treat the infection was defined as a recurrence of infection in the same hip. The average follow-up was five years (2-15 years). RESULT: There were four (12.9 %) failures during the study period at an average of 15 months (9-21 months) after partial single-stage revision. Of the 31 patients, 27 (87.1 %) patients had a satisfactory outcome and required no additional surgical or medical treatment for recurrence of infection. Acetabular cups were revised in 22 patients and femoral stems in nine patients. The mean post-operative Harris hip score at the most recent assessment was 74.6 (68-82). CONCLUSIONS: Treatment of chronic infectedTHA with retention of the well-fixed implant in a single-stage exchange can be fairly effective in the treatment of infection and achieving acceptable functional outcomes, which indicated that this may be an attractive alternative in highly selected patients. LEVEL OF EVIDENCE: Level IV, therapeutic study.
Entities:
Keywords:
Periprosthetic joint infection; Single-stage revision; Total hip arthroplasty
Authors: Donna M Urquhart; Fahad S Hanna; Sharon L Brennan; Anita E Wluka; Karin Leder; Peter A Cameron; Stephen E Graves; Flavia M Cicuttini Journal: J Arthroplasty Date: 2009-10-30 Impact factor: 4.757
Authors: Miguel M Gomez; Timothy L Tan; Jorge Manrique; Gregory K Deirmengian; Javad Parvizi Journal: J Bone Joint Surg Am Date: 2015-09-16 Impact factor: 5.284
Authors: Jeong Joon Yoo; Young Sam Kwon; Kyung-Hoi Koo; Kang Sup Yoon; Young-Min Kim; Hee Joong Kim Journal: Int Orthop Date: 2008-08-13 Impact factor: 3.075
Authors: Thomas Ilchmann; Werner Zimmerli; Peter Emil Ochsner; Bernhard Kessler; Lukas Zwicky; Peter Graber; Martin Clauss Journal: Int Orthop Date: 2015-07-30 Impact factor: 3.075
Authors: Dariusz Marczak; Marek Synder; Marcin Sibiński; Michał Polguj; Julian Dudka; Jacek Kowalczewski Journal: Int Orthop Date: 2017-05-18 Impact factor: 3.075
Authors: Moneer M Abouljoud; David Backstein; Andrew Battenberg; Matthew Dietz; Alejo Erice; Andrew A Freiberg; Jeffrey Granger; Adam Katchky; Anton Khlopas; Tae-Kyun Kim; Per Kjaersgaard-Andersen; Kyung-Hoi Koo; Yona Kosashvili; Percia Lazarovski; Jennifer Leighton; Adolph Lombardi; Konstantinos Malizos; Jorge Manrique; Michael A Mont; Marianthe Papanagiotoy; Rafael J Sierra; Nipun Sodhi; John Stammers; Maik Stiehler; Timothy L Tan; Katsufumi Uchiyama; Derek Ward; Anna Ziogkou Journal: J Arthroplasty Date: 2018-10-19 Impact factor: 4.757